In addition, cisplatin treatment with LINC01518 depletion resulted in a ~ 1.4-fold increase in caspase 3/7 activity in HNSCC cells compared to cells treated with cisplatin and ASO-NS (Fig. 2I). The gene discussed is CASP3; the disease is head and neck squamous cell carcinoma.